With the analysis among 750 patents, we discovered top 236 key players by total patent application. Hrain Biotechnology Co. Ltd., Shanghai Cell Therapy Group Co. Ltd., Noile-Immune Biotech, Inc. are dominant in this area. They take 13.47% of the total patent filing.
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 51
Shanghai Cell Therapy Group Co. Ltd.
Shanghai Shi, China
Patent: 24
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 24
Shanghai Cellular Biopharmaceutical Group Ltd.
Shanghai Shi, China
Patent: 21
Imperial Cancer Research Technology
Guangdong Sheng, China
Patent: 19
Cellular Biomedicine Group, Inc.
California, United States
Patent: 16
California, United States
Patent: 14
Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd.
Shanghai Shi, China
Patent: 14
AVANT Immunotherapeutics, Inc.
Massachusetts, United States
Patent: 12
With the analysis among 104 patents, we discovered top 12 start-ups by total patent application. Hrain Biotechnology Co. Ltd., Noile-Immune Biotech, Inc., A2 Biotherapeutics, Inc. are active in this area.
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 51
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 24
California, United States
Patent: 14
Beijing Immunochina Pharmaceuticals Co., Ltd.
Beijing Shi, China
Patent: 4
Suzhou Kerui Gene Biotechnology Co. Ltd.
Jiangsu Sheng, China
Patent: 2
Juventas Cell Therapy Ltd.
Tianjin Shi, China
Patent: 2
Shanghai Shi, China
Patent: 2
Nanjing Bioheng Biotech Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Sonoma Biotherapeutics, Inc.
California, United States
Patent: 1
Nanjing CART Medical Technologies Co. Ltd.
Jiangsu Sheng, China
Patent: 1
With the analysis among related 494 patents applied in the last 5 years. We discover 219 most active companies in this area. The fast-growing Hrain Biotechnology Co. Ltd., Noile-Immune Biotech, Inc., Shanghai Cellular Biopharmaceutical Group Ltd. take 15.18% of patent filing during this period.
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 31
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 24
Shanghai Cellular Biopharmaceutical Group Ltd.
Shanghai Shi, China
Patent: 20
Guangdong Sheng, China
Patent: 17
Cellular Biomedicine Group, Inc.
California, United States
Patent: 16
California, United States
Patent: 15
California, United States
Patent: 14
Shanghai Cell Therapy Group Co. Ltd.
Shanghai Shi, China
Patent: 13
Shandong Boan Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 10
Shanghai Cell Therapy Research Institute
undefined undefined
Patent: 9
With the analysis among related 494 patents in last 5 years, we discover 184 new entrants. Noile-Immune Biotech, Inc., Cellular Biomedicine Group, Inc., A2 Biotherapeutics, Inc. are the most active new entrants in this area.
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 24
Cellular Biomedicine Group, Inc.
California, United States
Patent: 16
California, United States
Patent: 14
Shandong Boan Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 10
Cellular Biomedicine Group HK Limited
undefined undefined
Patent: 9
SNC Stemcell Engineering Group Co., Ltd.
Carbiogene Therapeutics Co. Ltd.
Zhejiang Sheng, China
Patent: 9
Wuhan University of Science & Technology
Hubei Sheng, China
Patent: 7
Nanjing Blue Shield Biotech Co., Ltd.
Chengdu Shikangmei Biotechnology Co., Ltd.
Sichuan Sheng, China
Patent: 4
With the analysis among 351 patents, we discovered top 74 universities and scientific research institutions by total patent application. Yale University, The Johns Hopkins University, University College Cork are dominant in this area. They take 33.90% of the total patent filing.
Connecticut, United States
Patent: 30
The Johns Hopkins University
Wuhan University of Science & Technology
Hubei Sheng, China
Patent: 7
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 6
Shanghai Shi, China
Patent: 5
University of Southern California
California, United States
Patent: 4
Aichi-ken, Japan
Patent: 3
California Institute of Technology
California, United States
Patent: 3
Beijing Shi, China
Patent: 3